Rituximab-induced Acute Thrombocytopenia in Granulomatosis with Polyangiitis

Intern Med. 2018 Aug 1;57(15):2247-2250. doi: 10.2169/internalmedicine.0335-17. Epub 2018 Mar 9.

Abstract

A 72-year-old Japanese woman diagnosed with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis was admitted to our hospital with hearing loss, temporal pain, and sudden blindness. We finally diagnosed recurrent granulomatosis with polyangiitis and initiated methyl-prednisolone pulse therapy (1,000 mg) followed by prednisolone (30 mg/day) and rituximab (RTX). After the third RTX administration, she developed bloody stools along with acute thrombocytopenia and low complement levels. We diagnosed rituximab-induced acute thrombocytopenia (RIAT), and her platelet counts spontaneously recovered. This case suggests that after RTX therapy RIAT may sometimes cause severe thrombocytopenia, and that monitoring the complements may be useful for making an early diagnosis of RIAT.

Keywords: granulomatosis with polyangiitis; rituximab-induced acute thrombocytopenia.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / complications
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / drug therapy*
  • Female
  • Granulomatosis with Polyangiitis / complications
  • Granulomatosis with Polyangiitis / drug therapy*
  • Humans
  • Prednisolone / therapeutic use
  • Rituximab / adverse effects*
  • Rituximab / therapeutic use
  • Thrombocytopenia / chemically induced*
  • Treatment Outcome

Substances

  • Rituximab
  • Prednisolone